Expired Tender USA ICB TOT Ref. 19317235

NeuroNEXT Clinical Trials (U01 - Clinical Trial Tender - 19317235

Tender notice from USA, published on 22 Dec 2017.

Executive Summary

The NATIONAL INSTITUTES OF HEALTH has issued a Tender notice for the procurement of a NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional) in the USA. This Tender notice was published on 22 Dec 2017 and is scheduled to close on 07 Jan 2021, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 19317235, while the tender notice number is PAR-18-528 and Register on the platform.

Key facts

Summary
NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional)
TOT Ref. No.
19317235
Document Ref. No.
PAR-18-528
Country
USA
Notice type
Tender
Competition
ICB
Publication date
22 Dec 2017
Bid deadline
07 Jan 2021
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender are invited for NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional)
CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Jan 07, 2021
Posted Date : Dec 21, 2017
Description: This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS`` strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol. Applicants do not need to be part of the existing NeuroNEXT infrastructure.

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for NeuroNEXT Clinical Trials (U01 - Clinical Trial Optional) was 07 Jan 2021. Bidding is closed.

This tender has been issued by NATIONAL INSTITUTES OF HEALTH in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 19317235. The purchaser document reference is PAR-18-528.

Browse other tenders from USA or search by relevant keywords and CPV classification.